Trial Profile
Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary) ; Oxygen
- Indications Bronchiolitis
- Focus Registrational; Therapeutic Use
- Acronyms NO-BRO
- Sponsors AIT; Beyond Air
- 13 May 2021 Pooled data of patients in the SST group from three studies (AIT-CP-BRONC01-01, AIT-CP-BRONC02-01 and AIT-CP-BRONC-03-01) were published in the Beyond Air media Media Release.
- 15 Jun 2020 According to a Beyond Air media release, data from this trial has been published in the online journal the Scientific Reports.
- 15 Jul 2019 According to a Beyond Air media release, the company has changed its name from AIT Therapeutics to Beyond Air.